CAL
CLX icon

Capital Analysts LLC’s Clorox CLX Stock Holding History

Capital Analysts LLC’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
204
+3
+1% +$288 ﹤0.01% 1167
2026
Q1 		$21K Sell
201
-34
-14% -$3.85K ﹤0.01% 1120
2025
Q4 		$24K Buy
235
+3
+1% +$326 ﹤0.01% 1066
2025
Q3 		$29K Buy
232
+2
+0.9% +$248 ﹤0.01% 987
2025
Q2 		$28K Sell
230
-154
-40% -$20.5K ﹤0.01% 928
2025
Q1 		$57K Buy
384
+3
+0.8% +$458 ﹤0.01% 757
2024
Q4 		$62K Sell
381
-1
-0.3% -$164 ﹤0.01% 708
2024
Q3 		$63K Sell
382
-72
-16% -$10.7K ﹤0.01% 674
2024
Q2 		$62K Buy
454
+81
+22% +$11.2K ﹤0.01% 663
2024
Q1 		$57K Buy
373
+2
+0.5% +$299 ﹤0.01% 638
2023
Q4 		$53K Buy
371
+2
+0.5% +$267 ﹤0.01% 636
2023
Q3 		$48K Buy
369
+1
+0.3% +$152 ﹤0.01% 611
2023
Q2 		$58K Buy
368
+138
+60% +$22.3K ﹤0.01% 553
2023
Q1 		$37K Buy
230
+18
+8% +$2.7K ﹤0.01% 634
2022
Q4 		$30K Sell
212
-46
-18% -$6.53K ﹤0.01% 696
2022
Q3 		$33K Buy
258
+17
+7% +$2.45K ﹤0.01% 640
2022
Q2 		$34K Sell
241
-474
-66% -$67.7K ﹤0.01% 627
2022
Q1 		$100K Sell
715
-30
-4% -$4.6K 0.01% 429
2021
Q4 		$130K Buy
745
+2
+0.3% +$333 0.01% 408
2021
Q3 		$123K Buy
743
+32
+5% +$5.51K 0.01% 413
2021
Q2 		$127K Buy
711
+1
+0.1% +$183 0.01% 402
2021
Q1 		$137K Buy
710
+202
+40% +$38.9K 0.01% 399
2020
Q4 		$103K Hold
508
– – 0.01% 305
2020
Q3 		$107K Hold
508
– – 0.01% 304
2020
Q2 		$111K Hold
508
– – 0.01% 267
2020
Q1 		$88K Hold
508
– – 0.01% 269
2019
Q4 		$78K Hold
508
– – 0.01% 336
2019
Q3 		$77K Buy
+508
New +$80.3K 0.01% 315
2019
Q2 		– Sell
-28
Closed -$4K – 692
2019
Q1 		$4K Buy
+28
New +$4.34K ﹤0.01% 579

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital Analysts LLC's CLX Position: Q2 2026 in Review

Capital Analysts LLC increased its Clorox (CLX) stake by 1.5% in Q2 2026, buying an estimated $288 and bringing the position to 204 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Capital Analysts LLC first reported a position in CLX in Q1 2019 and has held it in 29 quarters since. The position peaked at $137K in Q1 2021. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Capital Analysts LLC held 204 shares of Clorox worth $19K as of Q2 2026.
  • Capital Analysts LLC bought 3 Clorox shares in Q2 2026, an estimated $288.
  • Clorox made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1167 holding.
  • Capital Analysts LLC first reported a position in Clorox in Q1 2019 and has held it in 29 quarters since.
  • Capital Analysts LLC's Clorox position peaked at $137K in Q1 2021.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.